FDA grants priority review to Xolair (omalizumab) for children and adults with food allergies based on positive National Institutes of Health phase III study results
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposureInterim analysis results from first-of-its-kind phase III OUtMATCH study showed Xolair significantly increased the amount of peanut, milk, egg and cashew it took to cause an allergic reaction17 million people in the U.S. have confirmed food allergies and more than 40% of children and more than half of adults with food allergies have experienced a severe reaction at least once1,2,3Basel, 19 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration ...
Source: Roche Media News - December 19, 2023 Category: Pharmaceuticals Source Type: news
FDA grants priority review to Xolair (omalizumab) for children and adults with food allergies based on positive National Institutes of Health phase III study results
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposureInterim analysis results from first-of-its-kind phase III OUtMATCH study showed Xolair significantly increased the amount of peanut, milk, egg and cashew it took to cause an allergic reaction17 million people in the U.S. have confirmed food allergies and more than 40% of children and more than half of adults with food allergies have experienced a severe reaction at least once1,2,3Basel, 19 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration ...
Source: Roche Investor Update - December 19, 2023 Category: Pharmaceuticals Source Type: news
CARD Clinic to Release New Asbestos Research in 2024
The Center for Asbestos Related Disease has begun work on a series of new research articles scheduled to be released throughout 2024. The content will center around new studies concerning asbestos and autoimmune disease.
The articles will reveal details discovered in analyzing the health impact of people exposed to amphibole asbestos from Libby, Montana. This type of asbestos found in the former mining town takes less exposure to cause cancer than other types of the mineral such as chrysotile asbestos, which makes amphibole even more dangerous.
CARD’s first article is expected to be released in January 2024. ...
Source: Asbestos and Mesothelioma News - December 15, 2023 Category: Environmental Health Authors: Amy Edel Tags: Asbestos (general) Asbestos Exposure Clinical Trials/Research/Emerging Treatments Source Type: news
Kyverna Therapeutics Granted FDA Fast Track Designation for KYV-101 in the Treatment of Patients With Refractory Myasthenia Gravis
The announcement follows the recent IND clearance for KYV-101 to be used in Kyverna's KYSA-6 Phase 2 open-label, multicenter study
KYV-101 is a fully human CD19 CAR T-cell therapy designed for use in patients with B cell-driven autoimmune diseases
EM... Biopharmaceuticals, FDA Kyverna Therapeutics, chimeric antigen receptor, Myasthenia Gravis, autoimmune (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 13, 2023 Category: Pharmaceuticals Source Type: news
CAR T-Cell Therapy: Cure for Systemic Autoimmune Diseases? CAR T-Cell Therapy: Cure for Systemic Autoimmune Diseases?
CD19-directed CAR T-cell therapy led to persistent complete remission in 15 patients with three distinct autoantibody-dependent autoimmune diseases.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - December 11, 2023 Category: Allergy & Immunology Tags: Hematology-Oncology Source Type: news
CAR-T, recently used in a lupus patient, helps other autoimmune patients, too, in small study
SAN DIEGO — When the first lupus patient received CAR-T therapy, researchers watched in amazement as her autoimmune disease rapidly went into remission. Then, they monitored her disease anxiously for months, wondering if it would return — especially as her immune B cells began recovering. Now, two…#sandiego #pjutz #stanforduniversity (Source: Reuters: Health)
Source: Reuters: Health - December 10, 2023 Category: Consumer Health News Source Type: news
J & J to emphasize cancer drugs, stop much of its vaccine research
J&J to emphasize cancer drugs and stop much of its vaccine research Eight months into his tenure, Johnson & Johnson’s R&D chief is putting a big emphasis on medicines for cancer, treatment-resistant depression, and autoimmune disease. To sharpen that focus, R&D chief John Reed told STAT that the…#johnsonjohnsons #johnreed #stat (Source: Reuters: Health)
Source: Reuters: Health - December 6, 2023 Category: Consumer Health News Source Type: news
Five Health Conditions Linked to Subsequent Diagnosis of MS
TUESDAY, Dec. 5, 2023 -- Five health conditions are associated with subsequent diagnosis of multiple sclerosis, but they overlap with two other autoimmune diseases, according to a study published online Dec. 5 in Neurology.
Octave Guinebretiere,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 5, 2023 Category: Pharmaceuticals Source Type: news
Biogen vet's new startup raises nine-figure round, moves to Watertown
The startup led by former Biogen Inc. and Amgen Inc. executive Jo Viney is pushing into autoimmune diseases with the help of $121 million in new funds. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 4, 2023 Category: Biotechnology Authors: Rowan Walrath Source Type: news
I used to be a huge people pleaser, but when I became seriously ill I finally learned to say no
After being diagnosed with an autoimmune disease, I stopped trying to please everyone else. Now I have better relationships and a healthy, joyful lifeI ’m a recovering people pleaser. Suppressing and repressing my needs, desires, expectations, feelings and opinions used to be as natural to me as breathing. To me, it was normal to tell people what they wanted to hear (read: lie) to make them feel better. Yes, I’ll be there for Christmas. Yes, I’ ll do that for you. Yes, I can fit that in. And then I’d seethe with resentment and feelings of self-loathing, even as the Good Person in me knew I had ticked off at least s...
Source: Guardian Unlimited Science - December 3, 2023 Category: Science Authors: Natalie Lue Tags: Life and style Psychology Science Health & wellbeing Source Type: news
DNA Contamination In COVID-19 Vaccines May Explain Rise In Cancers, Clots, Autoimmune Diseases: Pathologist
Authored by Tom Ozimek and Jan Jekielek via The Epoch Times (emphasis ours), Clinical pathologist Dr. Ryan Cole has said that DNA contamination in some COVID-19 vaccines may be related to an…#clots #autoimmunediseases #tomozimek #janjekielek #epochtimes #ryancole #phd #novi #michigan #jeffkowalskyafp (Source: Reuters: Health)
Source: Reuters: Health - November 30, 2023 Category: Consumer Health News Source Type: news
Malpractice dos and don'ts: Primer scoops top RSNA award
The authors of a practical guide designed to help radiologists avoid malpractice claims have received one of 17 magna cum laude awards handed out by the RSNA 2023 judges. Another prizewinner is about imaging of syphilis.
"The majority of radiologists will face litigation in their careers," noted Luke Michael Wojdyla, a second-year radiology resident, and radiologist James Y. Chen, MD, both of UC San Diego Health in California, adding that in a 2021 survey, 71% of radiologists said they had been sued.
"Despite this, dedicated teaching of medicolegal issues is often lacking or incomplete in radiology training programs. Res...
Source: AuntMinnie.com Headlines - November 29, 2023 Category: Radiology Authors: Philip Ward Tags: MRI RSNA 2023 Source Type: news
Fourth COVID-19 Shot Beneficial in Patients With Autoimmune Rheumatic Diseases
TUESDAY, Nov. 28, 2023 -- For patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs (DMARDs), receiving a fourth COVID-19 mRNA vaccine reduces the risk for severe acute respiratory syndrome coronavirus 2... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 28, 2023 Category: Pharmaceuticals Source Type: news
Lupus Drug Fails to Reduce Symptoms in Mid-stage Study Lupus Drug Fails to Reduce Symptoms in Mid-stage Study
Roivant Sciences said on Monday its experimental drug to treat systemic lupus erythematosus failed to reduce symptoms of the autoimmune disease in a mid-stage study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 28, 2023 Category: Consumer Health News Tags: Rheumatology News Source Type: news
Can plunging into an agonisingly cold ice bath REALLY ease your pain? Holby City's Rosie Marcel says it's all but banished the debilitating symptoms of her autoimmune condition...
Rosie Marcel (pictured) takes ice baths to ease the symptoms of Behcet's disease, an agonising immune condition that causes painful red lumps all over the body. (Source: the Mail online | Health)
Source: the Mail online | Health - November 22, 2023 Category: Consumer Health News Source Type: news
